• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Eidresha, W. (2021). SERUM LIPOPOLYSACCHARIDE BINDING PROTEIN AS A PREDICTOR AND PROGNOSTIC BIOMARKER FOR CIRRHOSIS RELATED ACUTE KIDNEY INJURY. ALEXMED ePosters, 3(2), 51-52. doi: 10.21608/alexpo.2021.76449.1162
Walaa Ahmed Eidresha. "SERUM LIPOPOLYSACCHARIDE BINDING PROTEIN AS A PREDICTOR AND PROGNOSTIC BIOMARKER FOR CIRRHOSIS RELATED ACUTE KIDNEY INJURY". ALEXMED ePosters, 3, 2, 2021, 51-52. doi: 10.21608/alexpo.2021.76449.1162
Eidresha, W. (2021). 'SERUM LIPOPOLYSACCHARIDE BINDING PROTEIN AS A PREDICTOR AND PROGNOSTIC BIOMARKER FOR CIRRHOSIS RELATED ACUTE KIDNEY INJURY', ALEXMED ePosters, 3(2), pp. 51-52. doi: 10.21608/alexpo.2021.76449.1162
Eidresha, W. SERUM LIPOPOLYSACCHARIDE BINDING PROTEIN AS A PREDICTOR AND PROGNOSTIC BIOMARKER FOR CIRRHOSIS RELATED ACUTE KIDNEY INJURY. ALEXMED ePosters, 2021; 3(2): 51-52. doi: 10.21608/alexpo.2021.76449.1162

SERUM LIPOPOLYSACCHARIDE BINDING PROTEIN AS A PREDICTOR AND PROGNOSTIC BIOMARKER FOR CIRRHOSIS RELATED ACUTE KIDNEY INJURY

Article 120, Volume 3, Issue 2, June 2021, Page 51-52  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2021.76449.1162
View on SCiNiTO View on SCiNiTO
Author
Walaa Ahmed Eidresha email
Department of Internal Medicine, Faculty of Medicine, University of Alexandria, Egypt
Abstract
• Acute kidney injury (AKI), defined as an increase in serum creatinine ≥ 0.3 mg/dL (26.5 µmoL/L) ≤ 48 hours, or a 50% increase from baseline, is one of the most serious complications of liver cirrhosis. It occurs in about 19% of hospitalized cases with liver cirrhosis and it carries a bad prognosis. The acute kidney dysfunction is associated with mortality in cases with cirrhosis. Moreover, it usually occurs concomitantly with other cirrhosis related complications like spontaneous bacterial peritonitis (SBP) and bleeding varices.
• Multiple factors could increase the risk for this complication including infections, hypovolemia, use of vasodilators, and non-steroidal anti-inflammatory drugs. Because of its unfavorable prognosis, potential triggers for AKI should be identified and removed in such cases. This includes correction of hypovolemia, discontinuation of nephrotoxic drugs, eradication of infections and management of other complications like variceal bleeding.
• Lipopolysaccharide binding protein (LBP) is an acute phase protein that is synthesized by the liver. It is secreted into the blood stream in response to infection with Gram-negative bacteria. Recent studies have reported that LBP is an important mediator of AKI in critically ill patients. However, after intensive online research, the current literature had poor data regarding the role of that biomarker in AKI in cirrhotic patients.
Keywords
Acute kidney injury (AKI); liver cirrhosis; Lipopolysaccharide binding protein (LBP)
Supplementary Files
download 0051-1162 Wala2_s-Poster (2).pdf
Statistics
Article View: 161
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.